MATALUNI, GIORGIA
 Distribuzione geografica
Continente #
NA - Nord America 7.801
EU - Europa 820
AS - Asia 297
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 8.933
Nazione #
US - Stati Uniti d'America 7.797
IT - Italia 324
KR - Corea 178
IE - Irlanda 161
UA - Ucraina 89
DE - Germania 81
CN - Cina 77
GB - Regno Unito 63
SE - Svezia 21
FI - Finlandia 19
FR - Francia 17
RU - Federazione Russa 13
IN - India 12
RO - Romania 10
BR - Brasile 6
TR - Turchia 5
CA - Canada 4
CH - Svizzera 4
JP - Giappone 4
KG - Kirghizistan 4
NL - Olanda 4
ES - Italia 3
HK - Hong Kong 3
IQ - Iraq 3
IR - Iran 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AU - Australia 2
BE - Belgio 2
CL - Cile 2
EU - Europa 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VN - Vietnam 2
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
JO - Giordania 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SG - Singapore 1
Totale 8.933
Città #
Wilmington 2.318
Houston 2.027
Woodbridge 1.805
Chandler 302
Fairfield 187
New York 164
Dublin 152
Ann Arbor 113
Medford 90
Ashburn 83
Cambridge 74
Seattle 67
Rome 66
Dearborn 54
Jacksonville 48
Beijing 45
Lawrence 43
Roebling 27
Milan 26
Piove di Sacco 20
San Diego 18
Palo Alto 15
Seoul 13
San Jose 11
Creede 8
Redwood City 8
Lodi 7
London 7
Norwalk 7
Verona 7
Florence 6
Mülheim 6
Istanbul 5
Kilburn 5
Menlo Park 5
Naples 5
San Francisco 5
Engelhard 4
Hounslow 4
Inverigo 4
Jinan 4
Kunming 4
Mountain View 4
Vicenza 4
Viterbo 4
Andover 3
Guidonia 3
Karbala 3
Lappeenranta 3
Nanjing 3
Palermo 3
Turin 3
Abbiategrasso 2
Ahmedabad 2
Atlanta 2
Bengaluru 2
Berlin 2
Billings 2
Boardman 2
Bogliasco 2
Bologna 2
Bolzano Vicentino 2
Brussels 2
Capaccio 2
Carugate 2
Chengdu 2
Chiswick 2
Council Bluffs 2
Delhi 2
Edmond 2
Essen 2
Falls Church 2
Gunzenhausen 2
Hefei 2
Helsinki 2
Ho Chi Minh City 2
Hong Kong 2
La Spezia 2
La Veta 2
Lausanne 2
Lissone 2
Littleton 2
Los Angeles 2
Modena 2
Montemesola 2
Montréal 2
Muenster 2
Nanchang 2
Nardò 2
New Bedfont 2
Osimo 2
Ovada 2
Padova 2
Paris 2
Pavia 2
Saint Petersburg 2
San Genesio Ed Uniti 2
San Giovanni Gemini 2
San Mateo 2
Scottsdale 2
Totale 7.998
Nome #
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 407
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 405
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 394
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 386
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 384
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 380
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 372
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 370
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 359
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 346
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 331
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 320
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 310
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 310
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 310
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 279
Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis 270
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 270
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 241
Regional variation of Guillain-Barré syndrome 227
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND ANTI-CONTACTIN-ASSOCIATED PROTEIN-1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 212
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 206
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND CONTACTIN-ASSOCIATED PROTEIN 1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 205
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 204
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 156
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 148
Current treatment practice of Guillain-Barré syndrome 112
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 106
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 100
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 97
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 97
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 59
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 56
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 56
Assessment of macular function by multifocal electroretinogram in patients with multiple sclerosis treated with fingolimod 54
Anti-HBs titers are not decreased after treatment with oral cladribine in patients with multiple sclerosis vaccinated against hepatitis B virus 44
The neurophysiological lesson from the Italian CIDP database 40
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey 32
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 31
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 31
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 30
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 29
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 27
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 26
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection 26
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 26
Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod 24
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration 22
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 21
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus 21
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 19
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 19
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 18
Response to Dr. Wee 15
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 15
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 14
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 14
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 12
Impact of environmental factors and physical activity on disability and quality of life in CIDP 12
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 11
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial 7
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 4
null 3
Totale 9.132
Categoria #
all - tutte 22.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019425 0 0 0 0 0 0 0 0 0 0 206 219
2019/20202.194 178 168 156 187 191 226 172 175 230 181 160 170
2020/20211.652 159 160 157 182 239 206 214 158 53 38 62 24
2021/2022456 28 35 13 38 26 44 16 19 39 40 29 129
2022/2023988 56 62 137 148 75 176 98 47 89 5 69 26
2023/2024323 70 12 27 25 33 66 29 13 24 22 2 0
Totale 9.132